368 related articles for article (PubMed ID: 16161053)
1. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.
Rollison DE; Newschaffer CJ; Tao Y; Pollak M; Helzlsouer KJ
Int J Cancer; 2006 Mar; 118(5):1279-84. PubMed ID: 16161053
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
4. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
6. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.
Hankinson SE; Willett WC; Colditz GA; Hunter DJ; Michaud DS; Deroo B; Rosner B; Speizer FE; Pollak M
Lancet; 1998 May; 351(9113):1393-6. PubMed ID: 9593409
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
[TBL] [Abstract][Full Text] [Related]
8. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density.
Diorio C; Pollak M; Byrne C; Mâsse B; Hébert-Croteau N; Yaffe M; Coté G; Bérubé S; Morin C; Brisson J
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1065-73. PubMed ID: 15894654
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factors and breast cancer risk in Chinese women.
Yu H; Jin F; Shu XO; Li BD; Dai Q; Cheng JR; Berkel HJ; Zheng W
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):705-12. PubMed ID: 12163322
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
[TBL] [Abstract][Full Text] [Related]
12. IGF-I and breast cancer: a meta-analysis.
Shi R; Yu H; McLarty J; Glass J
Int J Cancer; 2004 Sep; 111(3):418-23. PubMed ID: 15221971
[TBL] [Abstract][Full Text] [Related]
13. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.
Byrne C; Colditz GA; Willett WC; Speizer FE; Pollak M; Hankinson SE
Cancer Res; 2000 Jul; 60(14):3744-8. PubMed ID: 10919644
[TBL] [Abstract][Full Text] [Related]
14. Serum insulin-like growth factor-I and breast cancer.
Toniolo P; Bruning PF; Akhmedkhanov A; Bonfrer JM; Koenig KL; Lukanova A; Shore RE; Zeleniuch-Jacquotte A
Int J Cancer; 2000 Dec; 88(5):828-32. PubMed ID: 11072255
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast.
Bohlke K; Cramer DW; Trichopoulos D; Mantzoros CS
Epidemiology; 1998 Sep; 9(5):570-3. PubMed ID: 9730040
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
Rinaldi S; Kaaks R; Zeleniuch-Jacquotte A; Arslan AA; Shore RE; Koenig KL; Dossus L; Riboli E; Stattin P; Lukanova A; Toniolo P
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I, soy protein intake, and breast cancer risk.
Sanderson M; Shu XO; Yu H; Dai Q; Malin AS; Gao YT; Zheng W
Nutr Cancer; 2004; 50(1):8-15. PubMed ID: 15572292
[TBL] [Abstract][Full Text] [Related]
18. Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause.
Verheus M; Peeters PH; Kaaks R; van Noord PA; Grobbee DE; van Gils CH
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):451-7. PubMed ID: 17372240
[TBL] [Abstract][Full Text] [Related]
19. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
Vatten LJ; Holly JM; Gunnell D; Tretli S
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402
[TBL] [Abstract][Full Text] [Related]
20. The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women.
dos Santos Silva I; Johnson N; De Stavola B; Torres-Mejía G; Fletcher O; Allen DS; Allen NE; Key TJ; Fentiman IS; Holly JM; Peto J
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):449-55. PubMed ID: 16537700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
